Compare to: Previous Statements by CHTP » Chelsea Therapeutics' CEO Hosts Conference to Discuss FDA's CRL to Northera (Transcript) » Chelsea Therapeutics International's CEO Discusses Q4 2011 Results - Earnings Call Transcript » Chelsea Therapeutics' CEO Presents FDA Advisory Committee Update - Conference Call (Transcript) » Chelsea Therapeutics International's CEO Discusses Q3 2011 Results - Earnings Call Transcript